DTIL — Precision BioSciences Inc · rev $10.8M

Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.

Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.

Use this DTIL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DTIL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DTIL SEC filings page. Lician reads the product cache first so this HTML stays unique to Precision BioSciences Inc even when a live quote feed is slow.

Precision BioSciences Inc latest statements (FY2025)

Latest cached year on this hub. Full DTIL income, balance, and cash tables.

  • Revenue$34.3M
  • Net Income-$45.7M
  • Total Assets$154.4M
  • Total Debt$0
  • Free Cash Flow-$65.9M

DTIL recent filings